81181 Atxn7 gene detc abnor allele
Also known as: ATXN7 repeat analysis, Spinocerebellar Ataxia 7 testing
Molecular analysis of the ATXN7 gene to detect abnormal CAG repeat expansions associated with Spinocerebellar Ataxia type 7.
In Plain Language
ataxia gene test; vision loss and coordination disorder testing
Clinical Context
Used to diagnose Spinocerebellar Ataxia type 7, characterized by progressive ataxia and retinal degeneration, in affected individuals.
RVU Information
CPT 81181 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81181?
CPT 81181 (Atxn7 gene detc abnor allele) is a Pathology & Lab code. Molecular analysis of the ATXN7 gene to detect abnormal CAG repeat expansions associated with Spinocerebellar Ataxia type 7.
Who uses CPT code 81181?
CPT 81181 is used by Genetics, Neurology, Ophthalmology. Used to diagnose Spinocerebellar Ataxia type 7, characterized by progressive ataxia and retinal degeneration, in affected individuals.
When is CPT 81181 used?
Used to diagnose Spinocerebellar Ataxia type 7, characterized by progressive ataxia and retinal degeneration, in affected individuals.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.